Assessment of Preserved Ratio Impaired Spirometry Using Pre- and Post-Bronchodilator Spirometry in a Randomly Sampled Symptomatic Cohort
Am J Respir Crit Care Med
.
2023 Nov 15;208(10):1129-1131.
doi: 10.1164/rccm.202305-0805LE.
Authors
Kate M A Magner
1
,
Mathew Cherian
2
,
G A Whitmore
3
,
Katherine L Vandemheen
1
,
Celine Bergeron
4
,
Andreanne Cote
5
,
Stephen K Field
6
,
Catherine Lemière
7
,
R Andrew McIvor
8
,
Shawn D Aaron
1
Affiliations
1
The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
2
Division of Pulmonary Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada.
3
Desautels Faculty of Management, McGill University, Montreal, Quebec, Canada.
4
Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
5
Centre de recherche, Hôpital Laval, Université Laval, Quebec, Quebec, Canada.
6
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
7
Department de Pulmonologie, Universite de Montreal, Montreal, Quebec, Canada; and.
8
Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.
PMID:
37413793
DOI:
10.1164/rccm.202305-0805LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Bronchodilator Agents* / therapeutic use
Forced Expiratory Volume
Humans
Pulmonary Disease, Chronic Obstructive*
Spirometry
Vital Capacity
Substances
Bronchodilator Agents
Grants and funding
FDN 154322/CIHR/Canada